ATE181361T1 - Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie - Google Patents

Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie

Info

Publication number
ATE181361T1
ATE181361T1 AT95932544T AT95932544T ATE181361T1 AT E181361 T1 ATE181361 T1 AT E181361T1 AT 95932544 T AT95932544 T AT 95932544T AT 95932544 T AT95932544 T AT 95932544T AT E181361 T1 ATE181361 T1 AT E181361T1
Authority
AT
Austria
Prior art keywords
sickle cell
globin
composition
cell anemia
treating sickle
Prior art date
Application number
AT95932544T
Other languages
English (en)
Inventor
Philippe Leboulch
Irving M London
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE181361T1 publication Critical patent/ATE181361T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
AT95932544T 1994-09-19 1995-09-19 Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie ATE181361T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30879594A 1994-09-19 1994-09-19

Publications (1)

Publication Number Publication Date
ATE181361T1 true ATE181361T1 (de) 1999-07-15

Family

ID=23195426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95932544T ATE181361T1 (de) 1994-09-19 1995-09-19 Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie

Country Status (8)

Country Link
US (2) US5861488A (de)
EP (1) EP0783575B1 (de)
JP (1) JPH10509027A (de)
AT (1) ATE181361T1 (de)
CA (1) CA2199832C (de)
DE (1) DE69510356D1 (de)
GR (1) GR3031229T3 (de)
WO (1) WO1996009385A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853975A (en) 1994-08-23 1998-12-29 Millennium Pharmaceuticals, Inc. Methods for identifying compositions for the treatment of body weight disorders, including obesity
WO1996009385A1 (en) * 1994-09-19 1996-03-28 Massachusetts Institute Of Technology Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease
ATE474460T1 (de) 2002-12-13 2010-08-15 Genetix Pharmaceuticals Inc Therapeutische retrovirus-vektoren für gentherapie
WO2010012002A1 (en) * 2008-07-25 2010-01-28 Saryna Medical Corporation Methods and systems for genetic analysis of fetal nucleated red blood cells
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
US9783822B2 (en) 2011-09-23 2017-10-10 Bluebird Bio, Inc. Gene therapy methods
UA114796C2 (uk) 2011-09-30 2017-08-10 Блубьод Байо, Інк. Спосіб підвищення ефективності трансдукції
GB201322798D0 (en) 2013-12-20 2014-02-05 Oxford Biomedica Ltd Production system
US10543257B2 (en) 2014-09-11 2020-01-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Lentiviral vector for treating hemoglobin disorders
EP3356520B1 (de) 2015-10-02 2022-03-23 The U.S.A. as represented by the Secretary, Department of Health and Human Services Lentivirales protein übertragungssystem zum rna-vermittelten genomeditieren
RU2021103425A (ru) 2016-02-12 2021-02-25 Блубёрд Био, Инк. Композиции, повышающие число копий вектора (чкв), и способы их применения
CN108883136A (zh) 2016-02-12 2018-11-23 蓝鸟生物公司 Vcn增强子组合物及其使用方法
US20230002777A1 (en) 2019-11-12 2023-01-05 Oxford Biomedica (Uk) Limited Production System
WO2023003844A1 (en) 2021-07-19 2023-01-26 2Seventy Bio, Inc. Vector manufacturing processes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2779192B2 (ja) * 1987-09-17 1998-07-23 マサチユセツツ・インスチチユート・オブ・テクノロジー ヒト赤血球特異的転写エンハンサー
US5239061A (en) * 1990-06-20 1993-08-24 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
US5631162A (en) * 1993-06-11 1997-05-20 Massachusetts Institute Of Technology Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
CA2165679A1 (en) * 1993-06-21 1995-01-05 Tim M. Townes Anti-sickling hemoglobin
WO1996009385A1 (en) * 1994-09-19 1996-03-28 Massachusetts Institute Of Technology Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease

Also Published As

Publication number Publication date
DE69510356D1 (de) 1999-07-22
EP0783575B1 (de) 1999-06-16
US6051402A (en) 2000-04-18
WO1996009385A1 (en) 1996-03-28
CA2199832A1 (en) 1996-03-28
GR3031229T3 (en) 1999-12-31
JPH10509027A (ja) 1998-09-08
EP0783575A1 (de) 1997-07-16
CA2199832C (en) 2000-08-01
US5861488A (en) 1999-01-19

Similar Documents

Publication Publication Date Title
ATE181361T1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DE59611371D1 (de) Verfahren zur Herstellung von Erythropoietin frei von tierischen Proteinen
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69430990T2 (de) Zusammensetzung und methode zur anreicherung von weissen blutzellen aus menschlichem vollblut
EA200100502A1 (ru) СПОСОБЫ И КОМПОЗИЦИЯ ДЛЯ ВОССТАНОВЛЕНИЯ КОНФОРМАЦИОННОЙ СТАБИЛЬНОСТИ БЕЛКА СЕМЕЙСТВА p53
NO963742L (no) Fremgangsmåte til å stimulere hematopoese med hemaglobin
DE3280479T2 (de) Rekombinante DNS-Mittel und Verfahren
ATE257392T1 (de) Verfahren zur modulierung der neovaskularisierung und/oder des wachstums von kollateraler arterien und / oder anderer arterien aus bestehenden arteriolären verbindungen
DE69927507D1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
ATE342278T1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE59962T1 (de) Thrombin bindender stoff und verfahren zu seiner herstellung.
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
ATE414417T1 (de) Translations-kontrollelemente für proteinexpression mit hoher ausbeute in den plastiden von höheren pflanzen und verfahren zu deren verwendung
ES2113878T3 (es) Proteina c hibrida.
ATE232399T1 (de) Verfahren zur modulierung des wachstums kollateraler arterien und / oder anderer arterien aus bestehenden arteriolen verbindungen
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
DE60102147D1 (de) Anti-gefrier proteine, deren herstellung und verwendung
DE69835813D1 (de) Verfahren zur kultivierung von zellen und zur vermehrung von viren
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ATE419348T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
DE3485773T2 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties